Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
584.00    5.00 (0.86%)
Bid:
583.00
Ask:
585.00
Spread: 2.00 (0.343%)
Market Cap: £849.08m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Directorate Change

9 Apr 2025 07:01

RNS Number : 2121E
SAGA PLC
09 April 2025
Β 

9 April 2025

Saga plc

Board changes

The Board of Saga announces that Sir Peter Bazalgette, Senior Independent Director, and Steve Kingshott, Executive Director, are stepping down from the Board with effect from today. These changes to the Board follow Saga's successful Insurance agreement with wholly owned UK subsidiaries of Ageas SA/NV, and reflect the Group's new simplified business model.

Sir Peter, who chairs the Nomination Committee, is also a member of the Remuneration Committee. The Company announces that Gareth Hoskin will become Senior Independent Director, Chair of the Nomination Committee and a member of the Remuneration Committee. Julie Hopes will become a member of the Nomination Committee. These changes take effect from 9 April 2025.

Sir Roger De Haan, Non-Executive Chairman of Saga, said:

"I would like to thank Sir Peter and Steve for all their hard work over the past years and the significant contributions they have each made. Their expertise in their respective fields of media and insurance have proven invaluable as we have reshaped Saga, positioning it for growth. We wish them well in their future endeavours."

Following the changes above, the membership of the Nomination and Remuneration Committees will be as follows:

Nomination Committee:

Gareth Hoskin (Chair), Anand Aithal. Sir Roger De Haan, Gemma Godfrey and Julie Hopes

Β 

Remuneration Committee:

Julie Hopes (Chair), Gemma Godfrey and Gareth Hoskin

Β 

There are no changes to the Audit, Innovation and Enterprise or Risk Committees.

Β 

Β 

For further information, please contact:Β 

Saga plc

3 Pancras SquareLondonN1C 4AG

Β 

Vicki Haynes, Company Secretary

Tel: 07803 602 139

Email: company.secretary@saga.co.uk

Β 

Emily Roalfe, Director of Investor Relations and Treasury

Tel: 07732 093 007

Email: emily.roalfe@saga.co.uk

Β 

Headland Consultancy

Susanna Voyle

Will Smith

Tel: 020 3805 4822

Tel: 07980 894 557

Tel: 07872 350 425

Email: saga@headlandconsultancy.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABCGDSSUGDGUI
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
24th Oct 20247:35 amRNSDirector Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.